Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Kelun Biotech publishes sac TMT breast cancer study in Annals of Oncology

Sichuan Kelun Biotech Biopharmaceutical published overall survival analysis from its Phase III OptiTROP Breast01 study in Annals of Oncology during the ESMO Congress in Madrid

We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.

Read the original at vir.com.vn →

More in Health & Medicine

More from Tuesday 27 October →